Vaporox
Littleton
About Vaporox
Vaporox was formed to commercialize Vaporous Hyperoxia Therapy (VHT), a patented and FDA-510(k)-cleared technology that represents a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs), as well as amputations, burns, frostbite, gangrene, pressure ulcers (bed sores), and skin grafts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.7M
- Last round: Corporate Round (Jul 2025)
- Website: vaporox.com
- Phone: (303) 558-5145
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/vaporox-7685 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.